NASDAQ:EYES - Second Sight Medical Products Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.23 +0.04 (+1.83 %)
(As of 05/25/2018 01:16 AM ET)
Previous Close$2.23
Today's Range$2.18 - $2.24
52-Week Range$0.90 - $2.58
Volume274,359 shs
Average Volume540,823 shs
Market Capitalization$145.26 million
P/E Ratio-3.78
Dividend YieldN/A
Beta3.05

About Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products logoSecond Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets prosthetic devices to restore functional vision of blind individuals in the United States, Canada, Europe, the Middle East, and Asia. It offers Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa. The company was formerly known as Second Sight LLC. and changed its name to Second Sight Medical Products, Inc. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

Receive EYES News and Ratings via Email

Sign-up to receive the latest news and ratings for EYES and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EYES
CUSIPN/A
Phone818-833-5000

Debt

Debt-to-Equity RatioN/A
Current Ratio1.33
Quick Ratio0.92

Price-To-Earnings

Trailing P/E Ratio-3.78
Forward P/E Ratio-3.98
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.96 million
Price / Sales18.67
Cash FlowN/A
Price / CashN/A
Book Value$0.05 per share
Price / Book44.60

Profitability

EPS (Most Recent Fiscal Year)($0.59)
Net Income$-28,510,000.00
Net Margins-387.35%
Return on Equity-307.76%
Return on Assets-194.77%

Miscellaneous

Employees112
Outstanding Shares66,630,000

Second Sight Medical Products (NASDAQ:EYES) Frequently Asked Questions

What is Second Sight Medical Products' stock symbol?

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

How were Second Sight Medical Products' earnings last quarter?

Second Sight Medical Products Inc (NASDAQ:EYES) issued its quarterly earnings data on Thursday, May, 10th. The medical device company reported ($0.17) EPS for the quarter. The medical device company had revenue of $0.98 million for the quarter. Second Sight Medical Products had a negative return on equity of 307.76% and a negative net margin of 387.35%. View Second Sight Medical Products' Earnings History.

When is Second Sight Medical Products' next earnings date?

Second Sight Medical Products is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Second Sight Medical Products.

What price target have analysts set for EYES?

1 brokerages have issued 12-month target prices for Second Sight Medical Products' stock. Their predictions range from $5.00 to $5.00. On average, they anticipate Second Sight Medical Products' share price to reach $5.00 in the next twelve months. View Analyst Ratings for Second Sight Medical Products.

What are Wall Street analysts saying about Second Sight Medical Products stock?

Here are some recent quotes from research analysts about Second Sight Medical Products stock:
  • 1. According to Zacks Investment Research, "Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California. " (5/17/2018)
  • 2. HC Wainwright analysts commented, "We expect that the second pilot study could start in late 3Q17 or early 4Q17 and report top-line data by the end of 2017. Investors may recall that this second pilot study is double-masked and slated to enroll up to 45 subjects. The primary endpoint is the percentage of subjects achieving complete wound healing (based on staining) on day 3. Assuming that the second pilot study shows OBG’s ability to heal corneal defects faster than the standard of care, as was seen in the first pilot study, we believe that EyeGate may only need to conduct a single pivotal study in 2018 before filing for regulatory approval. We note that the FDA has permitted EyeGate to pursue U.S. regulatory clearance for OBG through the de novo 510(k) pathway." (8/8/2017)

Who are some of Second Sight Medical Products' key competitors?

Who are Second Sight Medical Products' key executives?

Second Sight Medical Products' management team includes the folowing people:
  • Mr. Jonathan Will McGuire, Chief Exec. Officer, Pres and Director (Age 55)
  • Mr. Edward David Randolph, VP of Manufacturing (Age 60)
  • Mr. Stephen D. Okland Jr., Commercial VP for US & Canada (Age 54)
  • Gunnar Bjorg, Founder

When did Second Sight Medical Products IPO?

(EYES) raised $32 million in an initial public offering on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO.

Has Second Sight Medical Products been receiving favorable news coverage?

News headlines about EYES stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Second Sight Medical Products earned a coverage optimism score of 0.08 on Accern's scale. They also gave news headlines about the medical device company an impact score of 44.94 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Second Sight Medical Products' major shareholders?

Second Sight Medical Products' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Glassman Wealth Services (0.12%). Company insiders that own Second Sight Medical Products stock include Edward David Randolph, Gregg Williams, Jonathan Will Mcguire and Robert J Greenberg. View Institutional Ownership Trends for Second Sight Medical Products.

Which institutional investors are buying Second Sight Medical Products stock?

EYES stock was bought by a variety of institutional investors in the last quarter, including Glassman Wealth Services. View Insider Buying and Selling for Second Sight Medical Products.

How do I buy shares of Second Sight Medical Products?

Shares of EYES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Second Sight Medical Products' stock price today?

One share of EYES stock can currently be purchased for approximately $2.23.

How big of a company is Second Sight Medical Products?

Second Sight Medical Products has a market capitalization of $145.26 million and generates $7.96 million in revenue each year. The medical device company earns $-28,510,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Second Sight Medical Products employs 112 workers across the globe.

How can I contact Second Sight Medical Products?

Second Sight Medical Products' mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The medical device company can be reached via phone at 818-833-5000 or via email at [email protected]


MarketBeat Community Rating for Second Sight Medical Products (EYES)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  252
MarketBeat's community ratings are surveys of what our community members think about Second Sight Medical Products and other stocks. Vote "Outperform" if you believe EYES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EYES will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Second Sight Medical Products (NASDAQ:EYES) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Second Sight Medical Products in the last 12 months. Their average twelve-month price target is $5.00, suggesting that the stock has a possible upside of 124.22%. The high price target for EYES is $5.00 and the low price target for EYES is $5.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.00$5.00$5.00$5.00
Price Target Upside: 124.22% upside116.45% upside116.45% upside339.44% upside

Second Sight Medical Products (NASDAQ:EYES) Consensus Price Target History

Price Target History for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ:EYES) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2018HC WainwrightSet Price TargetBuy$5.00LowView Rating Details
7/26/2016Rodman & RenshawReiterated RatingBuy$16.00N/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Second Sight Medical Products (NASDAQ:EYES) Earnings History and Estimates Chart

Earnings by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ:EYES) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.56 EPS
Next Year EPS Consensus Estimate: $-0.5 EPS

Second Sight Medical Products (NASDAQ EYES) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/30/2018N/AView Earnings Details
5/10/2018Q1 2018($0.17)$0.98 millionViewN/AView Earnings Details
3/7/2018Q4 2017($0.14)($0.13)$1.98 million$3.10 millionViewN/AView Earnings Details
11/2/2017Q3 2017($0.14)($0.12)$1.54 million$1.61 millionViewN/AView Earnings Details
8/1/2017Q2 2017($0.14)($0.13)$1.43 million$2.24 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.14)($0.18)$1.32 million$1.01 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.17)($0.24)$1.76 million$0.72 millionViewListenView Earnings Details
11/2/2016Q316($0.16)($0.15)$2.36 million$1.20 millionViewN/AView Earnings Details
7/28/2016Q216($0.15)($0.17)$2.66 million$1.04 millionViewListenView Earnings Details
4/28/2016Q116($0.16)($0.13)$1.38 million$1.05 millionViewListenView Earnings Details
3/3/2016Q415($0.14)($0.15)$2.47 million$2.40 millionViewN/AView Earnings Details
10/29/2015Q315($0.14)($0.13)$2.05 million$2.23 millionViewListenView Earnings Details
8/4/2015Q215($0.14)($0.14)$1.73 million$2.70 millionViewN/AView Earnings Details
5/13/2015Q115($0.12)$1.70 millionViewListenView Earnings Details
3/11/2015Q4 2014($0.18)$1.52 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Second Sight Medical Products (NASDAQ:EYES) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Second Sight Medical Products (NASDAQ EYES) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 34.70%
Institutional Ownership Percentage: 11.90%
Insider Trading History for Second Sight Medical Products (NASDAQ:EYES)
Institutional Ownership by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products (NASDAQ EYES) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2018Jonathan Will McguireCEOSell3,755$2.18$8,185.90100,873View SEC Filing  
5/3/2018Gregg WilliamsDirectorBuy6,756,757$1.48$10,000,000.36View SEC Filing  
11/20/2017Gregg WilliamsDirectorBuy17,020$1.18$20,083.60View SEC Filing  
11/17/2017Gregg WilliamsDirectorBuy5,420$1.17$6,341.40View SEC Filing  
4/7/2017Gregg WilliamsDirectorBuy4,000,000$1.00$4,000,000.00View SEC Filing  
12/1/2016Robert J GreenbergChairmanSell1,950$1.96$3,822.00172,911View SEC Filing  
6/3/2016Edward David RandolphVPSell5,104$4.01$20,467.04View SEC Filing  
6/2/2016Robert J GreenbergChairmanSell8,571$4.10$35,141.10172,911View SEC Filing  
4/18/2016Robert J GreenbergChairmanSell8,223$5.27$43,335.21181,134View SEC Filing  
12/7/2015Robert J. GreenbergChairmanSell17,969$5.30$95,235.70172,911View SEC Filing  
12/4/2015Anne-Marie Juliette RipleyVPSell2,500$5.50$13,750.00View SEC Filing  
6/4/2015Anne-Marie Juliette RipleyVPSell4,371$15.00$65,565.00View SEC Filing  
6/3/2015Robert J GreenbergCEOSell150,000$14.04$2,106,000.00View SEC Filing  
5/27/2015Anne-Marie Juliette RipleyVPSell45,629$13.04$595,002.16View SEC Filing  
3/23/2015Robert J GreenbergCEOSell100,000$13.28$1,328,000.00View SEC Filing  
11/19/2014Gregg WilliamsDirectorBuy111,111$9.00$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Second Sight Medical Products (NASDAQ EYES) News Headlines

Source:
DateHeadline
Critical Survey: Helius Medical Technologies (HSDT) and Second Sight Medical (EYES)Critical Survey: Helius Medical Technologies (HSDT) and Second Sight Medical (EYES)
www.americanbankingnews.com - May 21 at 11:19 AM
Zacks Investment Research Upgrades Second Sight Medical (EYES) to BuyZacks Investment Research Upgrades Second Sight Medical (EYES) to Buy
www.americanbankingnews.com - May 17 at 10:54 PM
Second Sight Medical (EYES) Given a $5.00 Price Target by HC Wainwright AnalystsSecond Sight Medical (EYES) Given a $5.00 Price Target by HC Wainwright Analysts
www.americanbankingnews.com - May 15 at 2:25 PM
Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor ConferenceSecond Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
finance.yahoo.com - May 14 at 11:42 AM
Second Sight Medical (EYES) Posts  Earnings ResultsSecond Sight Medical (EYES) Posts Earnings Results
www.americanbankingnews.com - May 11 at 2:19 PM
Second Sight Medical Products (EYES) CEO Will McGuire on Q1 2018 Results - Earnings Call TranscriptSecond Sight Medical Products' (EYES) CEO Will McGuire on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 11:38 AM
Second Sight Medical Products: Q1 Implant Results DisappointSecond Sight Medical Products: Q1 Implant Results Disappoint
seekingalpha.com - May 11 at 11:38 AM
Second Sight Reports First Quarter 2018 Financial ResultsSecond Sight Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 11 at 11:38 AM
Second Sight Medical Products: 1Q Earnings SnapshotSecond Sight Medical Products: 1Q Earnings Snapshot
finance.yahoo.com - May 11 at 11:38 AM
Second Sight Medical Products: Riding The Cash Roller Coaster To NowhereSecond Sight Medical Products: Riding The Cash Roller Coaster To Nowhere
seekingalpha.com - May 10 at 3:38 PM
BRIEF-Second Sight Completes $10 Mln Private Placement Of Common Stock With Chairman Of Board Of DirectorsBRIEF-Second Sight Completes $10 Mln Private Placement Of Common Stock With Chairman Of Board Of Directors
www.reuters.com - May 9 at 10:34 AM
Second Sight Medical (EYES) Director Gregg Williams Acquires 6,756,757 SharesSecond Sight Medical (EYES) Director Gregg Williams Acquires 6,756,757 Shares
www.americanbankingnews.com - May 7 at 10:26 PM
Second Sight Medical (EYES) Completes $10 Million Private Placement of Common Stock with Gregg Williams, ChairmanSecond Sight Medical (EYES) Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman
www.streetinsider.com - May 7 at 10:18 AM
Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of DirectorsSecond Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
finance.yahoo.com - May 7 at 10:18 AM
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference CallSecond Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
finance.yahoo.com - May 4 at 10:19 AM
Second Sight Medical (EYES) Upgraded at ValuEngineSecond Sight Medical (EYES) Upgraded at ValuEngine
www.americanbankingnews.com - May 4 at 12:12 AM
Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc ...Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc ...
globenewswire.com - May 2 at 10:24 AM
Head-To-Head Survey: Second Sight Medical (EYES) & Vision Sciences (CGNT)Head-To-Head Survey: Second Sight Medical (EYES) & Vision Sciences (CGNT)
www.americanbankingnews.com - April 29 at 9:21 AM
Second Sight Medical (EYES) Set to Announce Quarterly Earnings on TuesdaySecond Sight Medical (EYES) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 24 at 8:24 AM
Second Sight Medical (EYES) vs. Edap Tms (EDAP) Head-To-Head AnalysisSecond Sight Medical (EYES) vs. Edap Tms (EDAP) Head-To-Head Analysis
www.americanbankingnews.com - April 17 at 5:37 PM
Second Sight Medical (EYES) Announces Dr. Robert Greenbergs Resignation from Board of DirectorsSecond Sight Medical (EYES) Announces Dr. Robert Greenberg's Resignation from Board of Directors
www.streetinsider.com - April 10 at 10:53 AM
Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the CompanySecond Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company
finance.yahoo.com - April 10 at 10:53 AM
Second Sight Medical (EYES) PT Set at $5.00 by HC WainwrightSecond Sight Medical (EYES) PT Set at $5.00 by HC Wainwright
www.americanbankingnews.com - April 6 at 9:50 PM
Second Sight Medical (EYES) Downgraded by Zacks Investment ResearchSecond Sight Medical (EYES) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 31 at 4:56 PM
HC Wainwright Reiterates "$5.00" Price Target for Second Sight Medical Products (EYES)HC Wainwright Reiterates "$5.00" Price Target for Second Sight Medical Products (EYES)
www.americanbankingnews.com - March 25 at 11:41 AM
Second Sight Medical (EYES) Names John T. Blake as Chief Financial Officer - StreetInsider.comSecond Sight Medical (EYES) Names John T. Blake as Chief Financial Officer - StreetInsider.com
www.streetinsider.com - March 22 at 3:51 PM
Second Sight Medical (EYES) Names Gregg Williams to Board - StreetInsider.comSecond Sight Medical (EYES) Names Gregg Williams to Board - StreetInsider.com
www.streetinsider.com - March 16 at 3:39 PM
Second Sight Medical (EYES) Names Gregg Williams to BoardSecond Sight Medical (EYES) Names Gregg Williams to Board
www.streetinsider.com - March 16 at 11:34 AM
Second Sight Appoints Gregg Williams as Chairman of the Board of DirectorsSecond Sight Appoints Gregg Williams as Chairman of the Board of Directors
finance.yahoo.com - March 16 at 11:34 AM
Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering SymposiumSecond Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
finance.yahoo.com - March 9 at 10:41 AM
Second Sight Medical Products (EYES) CEO Will McGuire on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaSecond Sight Medical Products' (EYES) CEO Will McGuire on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 8 at 3:40 PM
Second Sight Reports Fourth Quarter and Full Year 2017 Financial ResultsSecond Sight Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 8 at 10:45 AM
Second Sight Medical Products (EYES) Announces  Earnings ResultsSecond Sight Medical Products (EYES) Announces Earnings Results
www.americanbankingnews.com - March 7 at 9:14 PM
Second Sight Medical Products, Inc. to Host Earnings CallSecond Sight Medical Products, Inc. to Host Earnings Call
finance.yahoo.com - March 7 at 3:38 PM
Second Sight Medical (EYES) Reports Expansion of Medicare ... - StreetInsider.comSecond Sight Medical (EYES) Reports Expansion of Medicare ... - StreetInsider.com
www.streetinsider.com - March 6 at 3:35 PM
Second Sight Medical (EYES) Reports Expansion of Medicare Coverage for Argus II Retinal ProsthesisSecond Sight Medical (EYES) Reports Expansion of Medicare Coverage for Argus II Retinal Prosthesis
www.streetinsider.com - March 6 at 10:52 AM
Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis SystemSecond Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System
finance.yahoo.com - March 6 at 10:51 AM
Second Sight Medical Products, Inc. to Present at the Inaugural LD ... - Business Wire (press release)Second Sight Medical Products, Inc. to Present at the Inaugural LD ... - Business Wire (press release)
www.businesswire.com - March 5 at 3:46 PM
Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018
finance.yahoo.com - March 5 at 11:14 AM
Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference CallSecond Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call
finance.yahoo.com - February 28 at 10:52 AM
Second Sight Medical Products (EYES) to Release Earnings on WednesdaySecond Sight Medical Products (EYES) to Release Earnings on Wednesday
www.americanbankingnews.com - February 28 at 1:58 AM
Second Sight Medical (EYES) Gains Following Entry into Singapore - StreetInsider.comSecond Sight Medical (EYES) Gains Following Entry into Singapore - StreetInsider.com
www.streetinsider.com - February 17 at 3:37 PM
Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis SystemSecond Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System
finance.yahoo.com - February 16 at 9:59 AM
Second Sight Medical Products (EYES) vs. Amedica (AMDA) Head-To-Head ReviewSecond Sight Medical Products (EYES) vs. Amedica (AMDA) Head-To-Head Review
www.americanbankingnews.com - February 15 at 12:46 PM
First Look At Second Sight - Seeking AlphaFirst Look At Second Sight - Seeking Alpha
seekingalpha.com - February 8 at 5:16 AM
Second Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent DevelopmentsSecond Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent Developments
finance.yahoo.com - February 8 at 5:16 AM
Second Sight (EYES) Catches Eye: Stock Jumps 12.7% - NasdaqSecond Sight (EYES) Catches Eye: Stock Jumps 12.7% - Nasdaq
www.nasdaq.com - February 6 at 3:17 PM
Second Sight (EYES) Catches Eye: Stock Jumps 12.7%Second Sight (EYES) Catches Eye: Stock Jumps 12.7%
finance.yahoo.com - February 6 at 3:17 PM
Second Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 ImplantsSecond Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 Implants
finance.yahoo.com - February 6 at 3:17 PM
33 Biggest Movers From Yesterday - Benzinga33 Biggest Movers From Yesterday - Benzinga
www.benzinga.com - February 6 at 5:25 AM

SEC Filings

Second Sight Medical Products (NASDAQ:EYES) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Second Sight Medical Products (NASDAQ:EYES) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Second Sight Medical Products (NASDAQ EYES) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.